Victoria M. McLeod

The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer

Stephin J. Vervoort, Sarah A. Welsh, Jennifer R. Devlin et al. · Cell · 2021 · 208 citations · Full text

Cancer Research, Signal Transduction, Signaling Pathway +9

Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy

Lisa M. Kaminskas, Victoria M. McLeod, Gemma M. Ryan et al. · Journal of Controlled Release · 2014 · 187 citations

Cancer Therapy, Lung Metastases, Oncology +10

A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems

Lisa M. Kaminskas, Victoria M. McLeod, Brian D. Kelly et al. · Nanomedicine Nanotechnology Biology and Medicine · 2011 · 168 citations

Nanomedicine, Antitumor Activity, Polymer-drug Conjugate +9

PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats

Lisa M. Kaminskas, Jagannath Kota, Victoria M. McLeod et al. · Journal of Controlled Release · 2009 · 144 citations

Sc Administration, Pharmaceutical Science, Drug Targeting +7

Pharmacokinetics and Tumor Disposition of PEGylated, Methotrexate Conjugated Poly-<scp>l</scp>-lysine Dendrimers

Lisa M. Kaminskas, Brian D. Kelly, Victoria M. McLeod et al. · Molecular Pharmaceutics · 2009 · 139 citations

Dendrimer Disposition, Nanomedicine, Pharmaceutical Science +13